Search clinical trials for: Modulation of FiO2

Total 10000 results

‹
1
2
...
86
87
88
89
90
91
92
...
199
200
›

Mahidol University
National Research Council of Thailand

Enrolling by invitation

Developing a Community Support Program to Help People Quit Smoking.

Smoking Cessation

Thailand
Thammasat University

Active, not recruiting

Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma (TXA-MELA)

Recurrence | Melasma | Treatment Outcome

Thailand
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France; Advanced Accelerator Applications

Completed

Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II (OCCLURANDOM)

Pancreatic Neuroendocrine Carcinoma

France
University of Rochester

Completed

Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); NCIC Clinical Trials Group; North Central Cancer... and other collaborators

Completed

Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Breast Cancer

United States, Canada
Varun Monga, MD
University of Iowa

Withdrawn

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Glioblastoma | Recurrent Glioblastoma

United States
XIANG YANQUN

Active, not recruiting

Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study

Chemotherapy Effect | Metastatic Nasopharyngeal Carcinoma

China
Guru Sonpavde
Pfizer; Hoosier Cancer Research Network

Withdrawn

Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma

Kidney Cancer | Clear-cell Renal Cell Carcinoma | RCC | Clear-cell Kidney Carcinoma

United States
University of California, San Francisco

Withdrawn

Outpatient Performed Pterygium Surgery Study (OPPS)

Pterygium of Conjunctiva and Cornea
RemeGen Co., Ltd.

Completed

Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration

Neovascular Age-related Macular Degeneration

China
National Cancer Institute (NCI)

Completed

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Neoplasm

United States
Eli Lilly and Company
Genentech, Inc.

Terminated

Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer

Breast Cancer

United States
Jonsson Comprehensive Cancer Center

Completed

Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Brain and Central Nervous System Tumors

United States
Instituto Mexicano del Seguro Social
Rodolfo Guardado Mendoza; Marco Antonio Ocampo Apolonio; Texar Alfonso Pereyra...

Completed

Effects of Fhytomenadione on Coronary Artery Calcification of Hemodialysis Patients

Coronary Calcification

Mexico
Hoffmann-La Roche

Completed

BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older

Ovarian Cancer

Belgium
Kim's Eye Hospital
Bayer

Completed

Intravitreal Aflibercept for Submacular Hemorrhage

Exudative Age-related Macular Degeneration

Korea, Republic of
M.D. Anderson Cancer Center
Celgene

Terminated

Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I

Malignant Gliomas

United States
NYU Langone Health
Celgene Corporation

Terminated

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma (rev/abraxane)

Relapsed or Refractory Multiple Myeloma

United States
Mikkael Sekeres MD
National Cancer Institute (NCI)

Completed

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes

Myelodysplastic Syndromes | Leukemia

United States
Hoffmann-La Roche

Completed

A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With Glioblastoma

Glioblastoma

United Kingdom, Austria, Croatia, France, Italy, Spain, Turkey, Romania, Portugal, Canada, Greece, Sweden, Bulgaria, Estonia, Latvia
Hoffmann-La Roche

Completed

A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer (BATMAN)

Breast Cancer

United Kingdom
Amgen

Completed

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Renal Impairment | Advanced Solid Tumors | Kidney Disease

United States
University of Oklahoma
Genentech, Inc.

Completed

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

Primary Peritoneal Carcinoma | Ovarian Carcinosarcoma | Advanced Ovarian Carcinoma

United States
Sunnybrook Health Sciences Centre
Celgene

Completed

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS (REMMYDYS)

Myelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | Angiogenesis

Canada
Hoffmann-La Roche

Withdrawn

A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)

Breast Cancer
Genentech, Inc.

Completed

A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

Solid Cancers

United States
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

Breast Cancer

France, Spain, Sweden, Russian Federation, Denmark, Slovakia
Pfizer

Terminated

A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer

Metastatic Colorectal Carcinoma

United States, Canada, Spain
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM) (DREAM)

Colorectal Cancer

France, Austria, Canada
Yale University
Genentech, Inc.

Completed

FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

Gastric Cancer | Gastroesophageal Cancer

United States
Genentech, Inc.

Completed

A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma | Metastases

United States
Clinical Research Center for Solid Tumor, Korea
Seoul National University Hospital

Completed

A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas

Glioblastoma | Astrocytoma

Korea, Republic of
Institut Curie

Unknown

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Intraocular Melanoma

France
Osaka Medical College

Unknown

S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery

Colorectal Cancer

Japan
David M. Brizel, MD
Genentech, Inc.; OSI Pharmaceuticals

Completed

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Head and Neck Cancer | Pharynx Cancer

United States
Pfizer

Completed

Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer (SUN 1064)

Breast Neoplasms

Australia, United States, Czech Republic, Hungary, Spain, Ukraine, France, Argentina, Austria, Belgium, Canada, Colombia, Finland, Germany, Ireland, Italy, Korea, Republic of, Netherlands, Panama, Poland, Portugal, Romania, Russian... and more
Accelerated Community Oncology Research Network
Bayer

Terminated

A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Terminated

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

Breast Cancer
Sanofi

Completed

Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties (DREAMS)

Sleep Initiation and Maintenance Disorders

France, Netherlands, Portugal, Spain, Estonia, Finland, Norway, Chile
Pfizer

Completed

Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer

Breast Neoplasms

Belgium, Sweden, Italy
Genentech, Inc.

Completed

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

Non-Small-Cell Lung Carcinoma | Neoplasm Recurrence, Local

United States
Nick Beije
Stichting Treatmeds

Recruiting

Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer (Apa/Enza-short)

Prostate Cancer

Netherlands
Wuhan Union Hospital, China

Not yet recruiting

Exploring Sintilimab + Bevacizumab + Decitabine for Advanced pMMR/MSS Colorectal Cancer (After 2+ Prior Therapies）

Colorectal Cancer Metastatic
Tongji Hospital

Recruiting

Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer

Ovarian Cancer

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular Carcinoma

Hepatocellular Carcinoma
Tanta University

Not yet recruiting

Effectiveness of Intravitreal Injection of Aflibercept 8 mg in Resistant Diabetic Macular Edema, Retinal Vein Occlusion and Myopic Choroidal Neovascularisation Patients

Diabetic Macular Edema (DME) | Myopic Choroidal Neovascularisation | Retinal Vein Occlusion (RVO)

Egypt
West China Hospital

Recruiting

Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
Jinling Hospital, China

Recruiting

Study on the Efficacy and Safety of Low-dose CTX as Maintenance Therapy for MM Unsuitable for Transplantation

Newly Diagnosed Multiple Myeloma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

Bevacizumab | Capecitabine | Metastatic Colorectal Cancer (mCRC) | Oxaliplatin | Tislelizumab | First-Line | MSS/pMMR | RAS-mutated

China
Nanfang Hospital of Southern Medical University

Recruiting

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China

‹
1
2
...
86
87
88
89
90
91
92
...
199
200
›

Subscribe